We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.5%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.38B
AUM Growth
-$101M
(-4.1%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-8.23%
Top 10 Holdings %
Top 10 Hldgs %
21.35%
Holding
276
New
33
Increased
38
Reduced
163
Closed
29
Top Buys
| 1 |
Modine Manufacturing
MOD
|
+$25M |
| 2 |
Wave Life Sciences
WVE
|
+$14.2M |
| 3 |
InterDigital
IDCC
|
+$12.9M |
| 4 |
SPX Corp
SPXC
|
+$12.4M |
| 5 |
Napco Security Technologies
NSSC
|
+$12.1M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
+$75.9M |
| 2 |
Churchill Downs
CHDN
|
+$25.4M |
| 3 |
Transmedics
TMDX
|
+$24M |
| 4 |
Treace Medical Concepts
TMCI
|
+$20.4M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$16.4M |
Sector Composition
| 1 | Technology | 24.67% |
| 2 | Healthcare | 22.79% |
| 3 | Industrials | 22.78% |
| 4 | Financials | 9.47% |
| 5 | Consumer Discretionary | 7.96% |
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, Emerald Advisers held 276 positions worth $2.38B, down 4.1% from $2.49B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Emerald Advisers withdrew a net $196M in Q2 2024, closing 29 positions and reducing 163 holdings. Its most notable exit was Treace Medical Concepts, an estimated $20.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Emerald Advisers opened a new position in Modine Manufacturing worth $26.1M.
- Emerald Advisers's largest Q2 2024 buy was Modine Manufacturing: 260,150 shares worth $26.1M.
- Emerald Advisers added most to InterDigital in Q2 2024, an estimated $12.9M increase.
- Emerald Advisers's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $75.9M.
- Emerald Advisers fully exited Treace Medical Concepts in Q2 2024, selling an estimated $20.4M.
- Emerald Advisers's ten largest holdings make up 21% of its $2.38B portfolio in Q2 2024.
- Emerald Advisers opened 33 new positions and closed 29 in Q2 2024.
- Emerald Advisers's portfolio value fell 4.1% quarter-over-quarter to $2.38B.
Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.